Don't believe anything in here delete worthy, but not going

New Post Public Reply Private Reply Replies (1) Message Board
steveadl
Don't believe anything in here delete worthy, but not going to write all this without having a copy for prosperity! Lol

Thanks for the thought our response agri. Please bare with me as only posting this on my ipad so can't change colour of quotes...

"And you think that's good business sense, a company that people will want to invest in?? Bad for shareholders "

For me its not really about that. I've said it's not ideal, but this is not the issue I'm trying to address with Kaymeyer (and seems will never get a response). This has nothing to do with the fundamental business of TelVue.

"Really? So being illiquid is good for the investor? how do you think the pps will rise if no one sells, no one buys, and company not transparent. Being illiquid is horrible for shareholders. PPS could stay at this level for 40 years just like ETCC has, mr lenfest's other company. "

Now whilst I don't necessity believe being illiquid is good or bad for an investors other way - it can be quite the reverse of what you're showing as an example. You're making a if assumption that no one would sell if the share price went higher. Now for the moment the full financials are by request only plus the PR's they release. Are you telling me you don't believe the stock price would rise if say eps in 2yrs is $5.00? At that point, lets just say a low PE of 10 and you have a stock worth $50.00 at which some holders will think "yup, that'll do me nicely". Someone else thinks hey, a stock trading at a PE of 10 that is growing 40%+ annually, sure! And bang, you have a market/trade.

Granted these figures are all plucked from thin air, but you asked how the share price would rise. Quite an easy assumption.

"So what are the fundamentals? no one knows!! No proxy, no PR, no shareholder meeting announcement, no transparency, no information, No benefit to the shareholder. So nothing to vote on this year?"

The basic fundamentals are the company has turned the corner into profitability, growth is increasing and around 40% annually (being conservative), they are expanding their customer base, branching our into new technologies as the market demands etc. this is all just based on the publicly available info. - shareholders can go I to more depth.

This is they key fundamentals that Kaymeyer seems to look past with his predictions and what I would like some reasoning on from him, yourself, or anyone else.

As for meeting etc. - who knows how late they'll do it, that's the point they're not reporting so can do at their leisure, whether you like it or not.

"I disagree as well as to the over agressive comments of some, on both sides of the argument, but without financials, liquidity, transparency or even a known business plan, this company is not shareholder friendly, won't you be surprised when it's sold for current list price and there goes the personal ATM. Sold or back to being a private company, that's what's coming, or maybe like ETCC no shareholder value, just payments of preferred dividends to the majority shareholder. No dividends, No splits, no transparency, no liquidity, no shareholder communication at all and definitely no shorts!!
So what are the proven positives here?? Not looking for rose colored glass hope, but proven information as to why someone should invest in this company???"

I agree in regard to aggressive comments, I don't believe I have been - and perhaps that's why my repeated requests for reasoning behind some of the comments here continue to go ignored.

I don't necessarily disagree that the company is not "investor friendly", but they are it exactly "shareholder unfriendly" either. That's more a point of opinion. I'm happy as a shareholder for them to keep plugging away at the business rather than spending $5k+ pa per shareholder to officially report, spend management time and focus to go around doing analyst roadshows etc - but that's just my opinion as a part owner of the co, not right or wrong, we're all entitled to our thoughts on this one.

You could be right, if the company were sold/privatised tomorrow - we may not receive a premium. But once next financials are released, and co. is worth a lot more than current market cap. - majority holder/management would be facing a flurry of lawsuits if they attempted anything at an unreasonably low price. I realise this brings us back to the whole financials argument, but for the sake of this point, lets just assume we're talking about actual holders who are looking at the audited reports.

The proven positives are as I stated earlier, increasingly profitable, growth increasing YOY and QOQ, rapidly growing industry, new markets, new customers, advancements in technology etc. Again, no one ever seems to address this amongst the huge amount of negative posts on the co.

Telvue Corp (TEVE) Stock Research Links

TEVE Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

DKS Facing Class Action Over Stock Slump Allegations

Updated Category News Views 2

A Burst Bubble at DICK'S Sporting Goods Grit your teeth and hang on—DICK'S Sporting Goods has stumbled, and investors are supposed to just weather the storm. From September 8, 2025, through August 24, 2026, if you held DICK'S shares, you've got some explaining to do, or at least you better start reading the fine print. Take note, folks: the deadline to file for lead...

Continue Reading
AI Memory Growth Pushes Limits at GMIF2026 Summit

Updated Category News Views 3

The Memory and Storage Race in the AI Era The 5th GMIF2026 Innovation Summit wrapped up in Shenzhen, and boy, was it a heavyweight bout. You could practically feel the tension in the room as industry giants sparred over the future of memory and storage in AI. This wasn't just another trade show pow-wow; this was a strategic chess match over where AI infrastructure is...

Continue Reading
Salveo Home Care Faces Class Action Over Labor Violations

Updated Category News Views 5

Another Company Lands in Hot Water Alright, it looks like Salveo Home Care is in the spotlight for all the wrong reasons. The home care provider—which should have been minding its P's and Q's—is now facing a class action suit. Why, you ask? Well, for allegedly skimping on wages and dodging legal obligations that leave their employees hanging dry. The Allegations are...

Continue Reading
Revamping Children's Radiotherapy: Leo Cancer Care's Vision

Updated Category News Views 4

The latest buzz in pediatric radiotherapy is shaking things up, and it’s all thanks to a game-changing shift in how treatment is delivered to kids. We're eyeballing Leo Cancer Care's innovative approach that might just redefine how these young patients face their battles. Standing Tall: A New Chapter in Proton Therapy In June, Stanford Medicine dished out the first...

Continue Reading
Melrose Fire Station Reaches Steel Topping Milestone

Updated Category News Views 2

Metal and Milestones: A New Era for Melrose Rolling into Melrose, Massachusetts, there's some serious action kicking off with the new Fire Engine 2 Station reaching a steel topping milestone. This phase isn't just about slapping on another beam; it's the crescendo of diligent teamwork from all the hands involved—from CTA Construction Managers to the clout of Ironworkers...

Continue Reading
IASO's FUCASO Shows Robust Results in 2026 Study

Updated Category News Views 6

IASO's Groundbreaking Results Stir Ripples in Oncology Folks, let me paint the picture here with the mighty, nitty-gritty details straight from the heart of China. The 2026 IMS Annual Meeting held a gem that could redefine how investors see the course of hematologic malignancy treatments. IASO Bio dropped some heavy data, showing their fine product, FUCASO, in a...

Continue Reading
Fuse Oncology Showcases New iRT Workflow at ASTRO

Updated Category News Views 4

Revolutionizing Charge Capture in Oncology Fuse Oncology's latest showcase at the ASTRO 2026 Annual Meeting isn't just about flashy presentations—it's looking to change how radiation oncology departments handle complex workflows. If you've ever delved into the maze of oncology billing, you know it's rife with opportunities for errors and inefficiencies. Skip one charge,...

Continue Reading
Leo Cancer Care's Upright Radiotherapy Milestone

Updated Category News Views 4

Upright Radiotherapy: Breaking Tradition in Cancer Care Here's a twist in the world of cancer treatment folks weren't exactly expecting. Leo Cancer Care has flipped the script by taking radiotherapy from a concept to an actual clinical reality with their Upright Platform. Yes, we're talking about standing up while getting treated, and it's not just a gimmick—it's a game...

Continue Reading
Accuray, Samsung Push Boundaries with Imaging Deal

Updated Category News Views 2

In a move that's got the healthcare industry buzzing, Accuray Incorporated (NASDAQ: ARAY) announced its partnership with Samsung NeuroLogica to supercharge the CyberKnife® System. This isn't just another collaboration; it's a strategic pivot to advance imaging capabilities, marrying Samsung's volumetric innovations with Accuray's established precision in robotic...

Continue Reading
Synagro Technologies Faces Lawsuit Over Unpaid Expenses

Updated Category News Views 6

Another Day, Another Lawsuit in Corporate America When it rains, it pours, especially in the corporate world where companies occasionally seem to forget they're playing with other people's livelihoods. Now, it's Synagro Technologies, Inc. facing the music. The company is under fire from Blumenthal Nordrehaug Bhowmik De Blouw LLP, a law firm well-versed in employee rights...

Continue Reading

Top 5 Most Recently Viewed Articles

Sprott Focus Trust Reports Quarterly Distribution and Insights

Updated Category News Views 195

Sprott Focus Trust Announces Quarterly Share Distribution In an uplifting update for investors, Sprott Focus Trust, Inc. (Nasdaq: FUND) has just declared a quarterly distribution of $0.1274 per share on its Common Stock. This distribution offers shareholders a choice between receiving payment in additional shares or cash. Set for disbursement on September 29, 2025,...

Continue Reading
Personal Injury Lawsuits: What You Need to Know Before Filing

Updated Category Personal Finance Views 1165

If you have been injured due to someone else's negligence or careless actions, you may be considering filing a personal injury lawsuit. Consulting a personal injury claim lawyer can help you understand your rights and the complexities involved in pursuing compensation. Personal injury lawsuits can be an effective way to recover damages for medical bills, lost wages, pain...

Continue Reading
Honeywell and Qualcomm Join Forces to Advance AI in Energy Sector

Updated Category News Views 188

Collaborating to Enhance AI Solutions in Energy Honeywell (NASDAQ: HON) and Qualcomm (NASDAQ: QCOM) Technologies, Inc. are making headlines with their groundbreaking collaboration aimed at revolutionizing artificial intelligence (AI) solutions within the energy sector. This partnership is a significant step towards enhancing Honeywell's automation offerings by seamlessly...

Continue Reading
Celebrating Diversity: The Best Gift for Foodies This Season

Updated Category News Views 106

Celebrating the Best Gift for Foodies Packed with Purpose (PwP), a Certified Woman-Owned and B Corp gifting company, has made headlines with its Black-Owned Spotlight Gift Basket, recently awarded as the Best Gift for Foodies. Understanding the Award Recognition This prestigious recognition comes from the USA Today 10Best Readers' Choice Awards, where a dedicated panel of...

Continue Reading
Coloplast A/S Updates Organic Growth and EBIT Margin Guidance

Updated Category News Views 620

Coloplast A/S Adjusts Financial Guidance for FY 2024/25 Coloplast A/S has revised its financial expectations for FY 2024/25, particularly in terms of organic growth and EBIT margin before special items. The anticipated organic growth has been adjusted to approximately 7%, down from the previous expectation of 8-9%. Additionally, the EBIT margin is now projected to be in...

Continue Reading